The latest news, stories and exciting findings from across the Oxford cancer research community
Oxford Cancer launches 2025 OCION Funding Scheme
13 June 2025
The 2025 Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is now open!
OxCODE funding scheme awards 2025
12 June 2025
Congratulations to Adam Creamer, Pengfei Li, Francisco Lopez-Cuevas, Yuqi Shen and their collaborators who have been awarded funding in the sixth round of the OxCODE Funding Scheme.
New vaccines that aim to prevent cancer: Starting the conversation
11 June 2025
Bringing together academics, clinicians and members of the public to explore the possibilities and challenges of vaccines for cancer prevention.
Celebrating two years of the Oxford Cancer Immuno - Oncology Network
11 June 2025
Professor Tim Elliott, Co- Director of Oxford Cancer, launched the Oxford Cancer Immuno-Oncology Network (OCION) at the inaugural OCION Symposium in June 2023 [pictured]. With our third annual symposium due to take place this month, we look back at some of OCION’s key achievements.
New research reveals druggable target arising from chromosomal rearrangement in aggressive leukaemia
10 June 2025
Researchers at the University of Oxford have uncovered a potential new therapeutic target in a particularly aggressive and hard-to-treat form of leukaemia.
Oxford Cancer hosts the inaugural Oxford Liver Cancer Centre of Excellence Symposium
27 May 2025
The first Oxford Liver Cancer Centre of Excellence Symposium took place on Thursday 22nd May in the Richard Doll Building.
Molecule enabling new leukaemia treatments discovered
22 May 2025
Researchers at the Shi Lab have discovered a first-in-class LSD1 PROTAC degrader, which opens up new therapeutic paths for the treatment of acute myeloid leukaemia. PROTAC degraders are molecules that degrade proteins by using the cell’s own machinery, binding to both the target protein and an E3 ligase, which marks it for degradation by the proteasome.
Oxford Cancer shortlisted for Vice-Chancellor’s Award
20 May 2025
The Oxford Cancer Team were finalists in the 'Excellence across Oxford' category at this year's Vice Chancellor's Awards.
Vice-Chancellor's Breakthrough Researcher Award for Dr Joshua Bull
20 May 2025
The University honoured remarkable talent and dedication to excellence on Thursday 15 May as the winners of the Vice-Chancellor's Awards 2025 were announced. Congratulations to Dr Joshua Bull from the Mathematical Institute, who received the Breakthrough Researcher Award.
Professor Andrew McMichael elected to the US National Academy of Sciences
6 May 2025
The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.
New guidelines published for monitoring IBD patients to prevent bowel cancer
1 May 2025
Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Oxford Cancer launches CRIS Cancer Clinical Career Fellow Award 2025
30 April 2025
Together with the CRIS Cancer Foundation, Oxford Cancer has launched the CRIS Cancer Clinical Career Fellow Award 2025, a new opportunity for clinical academics aiming to integrate cancer research with medical practice. Designed to foster independent research careers, this fellowship offers funding of up to £74,600 annually for up to three years to support salaries, research expenses, and clinical activities.
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
New vaccines that aim to prevent cancer: Starting the conversation
14 April 2025
A joint event from the Centre for Personalised Medicine (CPM) & Oxford Centre for Cancer Early Detection and Prevention (OxCODE) on Monday 2nd June 2025.
CRUK funding for research into earlier detection of relapse in people with multiple myeloma
9 April 2025
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
£5.5m Research Funding to Transform Bowel Cancer Care
31 March 2025
Cancer Research UK and partners have today committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. The team will be co-led by Professor Simon Leedham from the Nuffield Department of Medicine at the University of Oxford.
Project submissions welcome for the DPhil in Cancer Science
28 March 2025
The DPhil in Cancer Science is inviting PIs from across Oxford University’s medical, physical, engineering, data, and mathematical sciences to submit their project ideas for its 2026 intake.
Daily physical activity, even at light intensities, linked to lower cancer risk
27 March 2025
A study led by researchers from Oxford Population Health has found that daily physical activity is linked to a lower risk of cancer. The number of steps taken daily may be more important for cancer risk than the intensity of activity.
Showcasing cutting edge-cancer research at the 12th Annual Oxford Cancer Symposium
27 March 2025
The 12th Annual Oxford Cancer Symposium, supported by the CRUK Oxford Centre, took place this year on the 18th March at the University's Mathematical Institute.
Join the Laboratory Efficiency Assessment Framework!
26 March 2025
From 2025, Cancer Research UK (CRUK) will require all new wet-lab grant applications to have sustainability accreditation. Join the Laboratory Efficiency Assessment Framework (LEAF) now for support in meeting these new requirements!